| Novel prostaglandin receptor modulators: a patent review (2002 - 2012) - part I: non-EP receptor modulators. | |
| | |
MedLine Citation:
|
PMID: 23151189 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Introduction: Prostaglandins and their G-protein coupled receptors play numerous physiological and pathophysiological roles especially in inflammation and its resolution. The variety of physiological effects mediated by prostanoids makes prostanoid receptors valuable drug targets and the research on prostaglandin receptor modulators is intensive. Prostaglandin receptor targeting drugs might be beneficial for the treatment of inflammatory, allergic, respiratory and cardiovascular disorders as well as treatment of pain but several novel fields of use such as cancer and ophthalmic diseases have also been found apart from these classical indications. Areas covered: Evaluation of the patent activity over the last decade (2002 - 2012) illustrates many potent and selective modulators of the distinct prostanoid receptors and some novel methods for their use besides the classical indications. By now, some prostaglandin receptor antagonists already have reached clinical development. Expert opinion: Though the structural diversity of compounds targeting prostanoid receptors is not really large, several highly potent agents with favorable properties have been developed. The clinical potential of FP, IP, TP and DP modulators remains to be investigated, while first very promising clinical results are available as far as CRTH2 is concerned. |
| | |
Authors:
|
Christina Lamers; Daniel Flesch; Manfred Schubert-Zsilavecz; Daniel Merk |
Related Documents
:
|
7009789 - Antagonism of excitatory amino acid-induced and synaptic excitation of spinal neurones ... 23613579 - Differential targeting of brain stress circuits with a selective glucocorticoid recepto... 23296719 - Co-immunoprecipitation protocol to investigate cytokine receptor-associated proteins, e... 1978779 - Excitatory amino acid pathways in brain-stimulation reward. 22969749 - Decoding high gonadotropin-releasing hormone pulsatility: a role for gnrh receptor coup... 2563769 - Characterization of l-glutamate action on the release of endogenous dopamine from the r... 18329679 - Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone recep... 15026049 - Tricyclic pyridones as functionally selective human gabaa alpha 2/3 receptor-ion channe... 19071149 - Synthesis of c3, c5, and c7 pregnane derivatives and their effect on nmda receptor resp... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-11-14 |
Journal Detail:
|
Title: Expert opinion on therapeutic patents Volume: - ISSN: 1744-7674 ISO Abbreviation: Expert Opin Ther Pat Publication Date: 2012 Nov |
Date Detail:
|
Created Date: 2012-11-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9516419 Medline TA: Expert Opin Ther Pat Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Goethe University Frankfurt am Main , Frankfurt , Germany merk@pharmchem.uni-frankfurt.de. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Nitrogen fertilization of the host plant influences production and pathogenicity of Botrytis cinerea...
Next Document: Systemic associations of dynamic retinal vessel analysis: a review of current literature.